Large-scale testing (Phase 3)Study completedNCT00242424
What this trial is testing
Safety and Immunogenicity of Inactivated Influenza Virus Vaccine Among Healthy Children 6-12 Weeks of Age
Who this might be right for
Inactivated Influenza Vaccine
Seattle Children's Hospital 1,375